The effect of Lactobacillus brevis KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial

Lignende værker

• Genomic analysis by deep sequencing of the probiotic Lactobacillus brevis KB290 harboring nine plasmids reveals genomic stability.
  af: Masanori Fukao, et al.
  Udgivet: (2013-01-01)
• Genomic Analysis by Deep Sequencing of the Probiotic Lactobacillus brevis KB290 Harboring Nine Plasmids Reveals Genomic Stability
  af: Fukao, Masanori, et al.
  Udgivet: (2013)
• Effects of probiotic Lactobacillus brevis KB290 on incidence of influenza infection among schoolchildren: an open-label pilot study
  af: Waki, N, et al.
  Udgivet: (2014)
• Short Communication: Oral Administration of Heat-killed Lactobacillus brevis KB290 in Combination with Retinoic Acid Provides Protection against Influenza Virus Infection in Mice
  af: Satomi, Shohei, et al.
  Udgivet: (2020)
• Is bran efficacious in irritable bowel syndrome? A double blind placebo controlled crossover study.
  af: Lucey, M R, et al.
  Udgivet: (1987)